IL-6 transgenic mouse model for extraosseous plasmacytoma. - Wikidata - wikimedia - TriplyDB

IL-6 transgenic mouse model for extraosseous plasmacytoma.

IL-6 transgenic mouse model for extraosseous plasmacytoma.

http://www.wikidata.org/entity/Q34009997

about

Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1 Adipose tissue and adipokines: the association with and application of adipokines in obesity Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas IL-6 and MYC collaborate in plasma cell tumor formation in mice.Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4 Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes.Tetraspanin CD37 protects against the development of B cell lymphoma IL-6 stimulates intestinal epithelial proliferation and repair after injury.Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death.Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.GP130 activation induces myeloma and collaborates with MYC.The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response.Neoplastic development in plasma cells.Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma The therapeutic potential of interleukin-6 in treating obesity.The multiple facets of premature aging in rheumatoid arthritis.Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis Micro-imaging of amyloid in mice.SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.SOCS3 deletion in B cells alters cytokine responses and germinal center output.Novel therapy for Crohn's disease targeting IL-6 signalling.Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia A role for AID in chromosome translocations between c-myc and the IgH variable region.Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation.Preclinical animal models of multiple myeloma Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice Effects of acute and chronic inflammation on B-cell development and differentiation.Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma.Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models

P2860

Q24814355-549EF320-8FE4-427E-8D91-3ABD21FFF195 Q26830052-4A75823E-7730-4113-A96D-471C300B9D53 Q27027729-7208FA89-805E-4B5C-BBB2-5647A868008B Q30444311-30095375-3A4E-49E9-8802-2600BFE955E1 Q30561836-FAFA1A2B-49EE-44A8-9BE4-5BAE0FFEC949 Q33392701-85EF7875-FFA0-45B9-945A-275D87CFABFC Q33567153-BDC208DD-3093-4C33-8D0D-0573751B39FD Q33706389-F1CB8A6B-1FF2-4D3D-95C1-5C98510E9785 Q34020937-7727F8C8-B27D-4617-BA6A-D1B2790A8189 Q34380431-EB5CA155-1FFE-435C-B718-07949E1309EC Q34440657-32862D20-4BEB-47A7-9835-9FEB5FAD1890 Q34509755-9B8FDC91-620F-4EEB-8742-73AF5825E6D7 Q34640584-9ADE3E37-7164-444A-BCD5-896403966035 Q34974240-A726156B-CA04-4859-81AD-F449AA3D0B34 Q35055356-24D30D85-4459-4FAA-88DC-2FACCA41B3B4 Q35145350-51C28363-7B2E-43EE-A180-9881EB8E352C Q35170906-0A445880-0A96-48AC-B646-12B89BBA1876 Q35170940-21AA938A-E42D-4BEE-90BF-9301AF5D4BAC Q35220037-FD5A3316-DB45-4636-9E01-4564DB064635 Q35247381-15F09290-3AC1-4F41-AB7F-537FD875A6FE Q35547260-44C8C50D-551E-44A1-858A-B2B62765ED74 Q35559238-16C32333-3593-4A55-B473-6846F165B0E8 Q35639988-22BEEC60-0874-4B37-BD13-7BDCB27739F5 Q35652050-0F2A4A48-5B2B-4A17-87BF-69D382C85281 Q35656129-FD8F5994-2325-41C7-8F28-16BD6EFFC7BD Q35663095-9A881A22-1DB5-4E3B-9260-9A3DE386831A Q35842497-B20E671F-5755-4B42-8273-A9A8E7E1D012 Q36146840-3E45E3C5-7E6C-4DA7-8E9B-CC00709F0568 Q36194829-360A798C-8611-4762-B756-C239C4E07DDA Q36229681-FAAC77F1-5363-4DB6-8F19-DCA17AA0445F Q36237736-C6251DF1-4165-41CD-9907-7AEA0663EBC5 Q36524036-081EE45B-34AC-4886-9337-E051086C749E Q36561366-D4790537-B533-4558-A732-7E2CBD410D73 Q37261989-F51AEFE4-A12A-42F3-A2BF-CA05325C96DE Q37369902-B5BEC3D4-3FE5-48CD-A5D3-03A4FB4830B6 Q37419452-77E32782-897F-4A56-944F-0F6D54258509 Q37490002-8B5EF119-9E07-4EBA-9EED-8E3A4BAD736D Q37692413-BEE63D46-76C8-438C-8344-56E7843776ED Q38016511-229C86DF-FBA1-4365-B6AD-3AD5EE1D029D Q38150849-1C73865B-163D-4649-8223-4F978780AFAB

P2860

IL-6 transgenic mouse model for extraosseous plasmacytoma.

http://www.wikidata.org/entity/Q34009997

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@ast

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@en

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@nl

type

label

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@ast

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@en

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@nl

prefLabel

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@ast

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@en

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@nl

P1433

Q34009997-B9166CAC-B47C-4C59-9C36-59BCE2FF17A6

P1476

Q34009997-F1E72E13-9B26-41E9-9AC9-D77884231FD9

P2093

Q34009997-2D4BC03F-F60C-4CC6-BFA6-13FAB3927ACF

Q34009997-746F9777-9DA3-4E23-B973-CBA9EF079ABA

Q34009997-A4101C62-6F01-4AE8-8E8C-05C6921DB7BA

Q34009997-A8769781-AAEA-4ACF-A9F5-0DBF7285CACC

Q34009997-DCA3F94A-330E-4171-A54F-53AB5D68A6D5

Q34009997-DD7069B4-2163-46BE-B7D3-6CD74A3F9058

Q34009997-E87B6604-F32B-46C4-A6A3-35C032EC1170

Q34009997-FC7AA10F-9EC5-4B9E-9941-64146629DDCA

P2860

Q34009997-02C9FB81-359A-4B46-9F87-E627142554FD

Q34009997-130C7409-CFB6-4E3C-B257-C61B65B7E373

Q34009997-18DD6B7B-A30D-405B-A7C8-272C670E2BC6

Q34009997-205D0D0E-70B0-4B47-93AB-A09CBDC93750

Q34009997-29852EBF-D55B-44CD-9B64-BC0569DD7AD3

Q34009997-2C3399BA-B8D6-44F1-85A2-3080C7CE0B05

Q34009997-2D5889BC-0CA1-4E72-B889-77D5675987DD

Q34009997-2DFF61A3-E4E5-4436-BD65-4B9C951D24B5

Q34009997-2E08CBAC-BB3E-4431-BA0F-F53237CE1812

Q34009997-2FF50076-412E-4C9F-B967-B0E9EB045EBB

P304

Q34009997-2F8F3DFB-136D-44A1-A5DC-7A0352D2FEB6

P31

Q34009997-5CC6A585-E816-4B1A-9C7A-DD22EC1F4797

P356

Q34009997-BEC27C30-28F3-4A41-9941-61B7156E8D3C

P407

Q34009997-E555F630-A0BB-4689-8DE0-7DF613F8BF50

P433

Q34009997-3F825518-68F5-45CB-BFD4-021898E718F2

P478

Q34009997-B7C9FAB8-4E53-4CAC-9DA7-5BF1ABE553D9

P50

Q34009997-6C064380-2B67-4CE5-83CE-A9F2FE965413

P577

Q34009997-684B0C29-0F93-4458-95BF-A03F38FE346F

P5875

Q34009997-41930B29-14F2-4185-9993-37114FABD95D

P698

Q34009997-FC8CDEF4-3CB3-436F-9E31-818D58FFED6E

P932

Q34009997-B83FFEB8-CF12-433D-89CA-88DBE4620C2A

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

IL-6 transgenic mouse model for extraosseous plasmacytoma.

@en

P2093

Alexander L Kovalchuk

http://www.w3.org/2001/XMLSchema#string

Allen E Coleman

http://www.w3.org/2001/XMLSchema#string

Jerrold M Ward

http://www.w3.org/2001/XMLSchema#string

Joong Su Kim

http://www.w3.org/2001/XMLSchema#string

Michael Potter

http://www.w3.org/2001/XMLSchema#string

Siegfried Janz

http://www.w3.org/2001/XMLSchema#string

Sung Sup Park

http://www.w3.org/2001/XMLSchema#string

Tadamitsu Kishimoto

http://www.w3.org/2001/XMLSchema#string

P2860

Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice.

Negative regulation of cytokine signaling: STAT-induced STAT inhibitor.

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.

Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility

The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.

IgG1 plasmacytosis in interleukin 6 transgenic mice.

Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation

Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.

Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.

Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells.

P304

1509-1514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.022643999

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Herbert C. Morse

P577

2002-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11554412

http://www.w3.org/2001/XMLSchema#string

P698

11805288

http://www.w3.org/2001/XMLSchema#string

P932

122221

http://www.w3.org/2001/XMLSchema#string